<i>Cdc42</i> defect reveals insights into microvilli organization and function in T cell immunity
Abstract
Microvilli on T cells differ from those on epithelial cells, exhibiting filopodia-like characteristics that facilitate the clustering of molecules essential for sensing and cell migration. Recently, they have also been recognized as the structures from which T cell immunological synaptosomes (TIS) are released. In this study, we examined a key determinant of microvilli organization during T cell development and explored the functional roles of these structures, particularly in relation to T cell behaviors. During thymocyte maturation, single-positive thymocytes were found to develop more and longer microvilli than double-positive thymocytes. However, the deletion or inhibition of Cdc42, a small Rho family protein, significantly reduced both the number and length of microvilli in single-positive thymocytes, leading to decreased cell mass. This reduction in microvilli correlates with a decrease in antigen recognition, leading to diminished T cell activation and adhesion, as well as reduced TIS production, while intrinsic migratory properties remain unaffected. These findings highlight the filopodia-like characteristics of T cell microvilli. In this context, Cdc42 contributes significantly to microvilli formation, thereby shaping T cell function.
Article Details
Journal Info
Proceedings of the National Academy of Sciences
National Academy of Sciences
Authors (11)
Won-Chang Soh
Life Sciences and Medical Convergence Gwangju Institute of Science and Technology
Sang-Moo Park
Life Sciences and Medical Convergence Gwangju Institute of Science and Technology
Jeong-Su Park
Life Sciences and Medical Convergence Gwangju Institute of Science and Technology
Hatice Karabulut
Life Sciences and Medical Convergence Gwangju Institute of Science and Technology
Hee-Tae Kang
Life Sciences and Medical Convergence Gwangju Institute of Science and Technology
Sun-Kyoung Kang
Life Sciences and Medical Convergence Gwangju Institute of Science and Technology
Min-Sang Kim
Life Sciences and Medical Convergence Gwangju Institute of Science and Technology
Jihwan Park
Life Sciences and Medical Convergence Gwangju Institute of Science and Technology
Sunjae Lee
Life Sciences and Medical Convergence Gwangju Institute of Science and Technology
Hye-Ran Kim
Division of Rare and Refractory Cancer, Tumor Immunology, Research Institute, National Cancer Center
Chang-Duk Jun
Life Sciences and Medical Convergence Gwangju Institute of Science and Technology